TAI’AN CITY, Shandong, China, Nov. 11 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (“CBP,” or the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that it will host a conference call at 10:00 a.m. EST on Thursday, November 13, 2008, to discuss the third quarter 2008 results.
Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer. The Company plans to release its earnings on November 12, 2008.
To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 888- 339-2688. International callers should dial 617-847-3007. The pass code for the call is 320 762 60.
If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Thursday, November 13, 2008 at 12:00 p.m. EST. To access the replay, dial 888-286-8010, international callers should dial 617-801-6888. The conference pass code is 14755104.
About China Biologic Products, Inc.
Through its indirect majority-owned subsidiary Shandong Taibang Biological Products Co. Ltd., China Biologic Products, Inc. (the “Company”), is principally engaged in the research, development, production and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. The Company’s human albumin products are mainly used to increase blood volume, and its immunoglobulin products are used for the treatment and prevention of diseases.
CONTACT: Company Contact, Mr. Y. Tristan Kuo, CFO of China Biologic
Products, Inc., +86-538-620-2206, or IR@chinabiologic.com; or Investor
Relations Contact, Mr. Crocker Coulson, President of CCG Investor
Relations, +1-646-213-1915 (NY office), or crocker.coulson@ccgir.com, for
CBPO
Web site: http://www.chinabiologic.com/
